Rockefeller Capital Management »

Urogen Pharma shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0k 112 17.98
2025-12-31 $2.6k 112 23.42
2022-06-30 $0 40 0.00

More positions owned by Rockefeller Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tidal Trust Iii Rockefeller Glob (RGEF)
Tidal Trust Iii Rockefeller Us S (RSMC)

View all positions for Rockefeller Capital Management

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Toronto-Dominion Bank
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
Silverarc Capital Management
Paradigm Biocapital Advisors
SG Americas Securities
Acorn Capital Advisors
Opaleye Management
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
D. E. Shaw & Co

View all funds holding Urogen Pharma